详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Xu, Rui-Hua[1] * ; Wang, Feng[1] ; Wang, Zi-Xian[1] ; Peng, Junjie[2] ; Liang, Xinjun[3] ; Cheng, Ying[4] ; Deng, Yanhong[5] ; Chen, Kehe[6] ; Zhang, Mingjun[7] ; Zhang, Jingdong[8] ; Wang, Wei[9] ; Cao, Bangwei[10] ; Jin, Yongdong[11]

; Sun, Meili[12] ; Lin, Yuan[13] ; Luo, Suxia[14] ; Li, Zhen[15] ; Yang, Liu[16] ; Wang, Qingyu[17] ; Zhu, Jun[17] ;

机构： [1]Sun Yat sen Univ, State Key Lab Oncol South China, Dept Med Oncol, Guangdong Prov Clin Res Ctr Canc,Canc Ctr, Guangzhou, Peoples R China [2]Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai, Peoples R China [3]Hubei Canc Hosp, Dept Abdominal Oncol, Wuhan, Peoples R China [4]Jilin Canc Hosp, Dept Med Oncol, Changchun, Peoples R China [5]Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou, Peoples R China [6]Peoples Hosp Guangxi Zhuang Autonomous Reg, Nanning, Peoples R China [7]Anhui Med Univ, Dept Oncol, Affiliated Hosp 2, Hefei, =, Peoples R China [8]Dalian Univ Technol, China Med Univ, Canc Hosp, Liaoning Key Lab Gastrointestinal Canc Translat Re, Shenyang, Peoples R China [9]First Peoples Hosp Foshan, Dept Gastrointestinal Oncol, Foshan, Peoples R China [10]Capital Med Univ, Beijing Friendship Hosp, Dept Oncol, Beijing, Peoples R China [11]Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Affiliated Canc Hosp, Sichuan Canc Ctr,Sichuan Clin Res Ctr Canc, Chengdu, Peoples R China [12]Shandong First Med Univ, Jinan Cent Hosp, Cent Hosp, Dept Oncol, Jinan, Peoples R China [13]Guangxi Med Univ Canc Hosp, Dept Gastrointestinal Surg, Nanning, Peoples R China [14]Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Med Oncol, Zhengzhou, Peoples R China [15]Linyi Canc Hosp, Dept Med Oncol, Linyi, Peoples R China [16]Hangzhou Med Coll, Peoples Hosp, Dept Med Oncol, Canc Ctr,Hangzhou Med Coll, Hangzhou, Peoples R China [17]Shanghai Henlius Biotech Inc, Shanghai, Peoples R China

出处：

DOI：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2025]版：

无

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2025]版：

无

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Sun Yat sen Univ, State Key Lab Oncol South China, Dept Med Oncol, Guangdong Prov Clin Res Ctr Canc,Canc Ctr, Guangzhou, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Updated efficacy and subgroup analysis of first-line serplulimab plus bevacizumab and XELOX versus placebo plus bevacizumab and XELOX in metastatic colorectal cancer: A phase 2/3 study

文献详情